Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Mayinglong Pharmaceutical Group Co Ltd
Research & Development
Mayinglong Pharmaceutical Group Co Ltd
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
|
Research & Development
-¥67.3m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Research & Development
-¥2.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Research & Development
-¥267m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Research & Development
-¥5.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Research & Development
-¥317.8m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Research & Development
-¥44.2m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
See Also
What is Mayinglong Pharmaceutical Group Co Ltd's Research & Development?
Research & Development
-67.3m
CNY
Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Research & Development amounts to -67.3m CNY.
What is Mayinglong Pharmaceutical Group Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-28%
Over the last year, the Research & Development growth was 14%. The average annual Research & Development growth rates for Mayinglong Pharmaceutical Group Co Ltd have been -8% over the past three years , -28% over the past five years .